is a complex neuropsychiatric disorder to which an as-yet-unknown number of genes contribute, interacting with each other and the environment. Linkage analyses have implicated several chromosomal regions as harboring schizophrenia susceptibility loci although rarely at levels commensurate with proposed thresholds for genome-wide significance. We systematically recruited Arab Israeli families multiply affected with schizophrenia from the catchment area of a Regional Mental Health Center. Clinical diagnoses were established by semistructured interviews and all other available sources of information under narrow, core and broad categories. Using 350 microsatellite markers, spaced at an average of 10.3 cM, we performed an autosomal scan in 155 subjects from 21 families. Linkage analysis employed affects only, multipoint, nonparametric (model-free) and also parametric (dominant and recessive) approaches. We detected significant evidence for a schizophrenia susceptibility gene at chromosome 6q23 with a nonparametric LOD score (NPL) of 4.60 (P ¼ 0.000004) under the broad diagnostic category and a parametric LOD score of 3.33 (dominant model). Under the core diagnostic category the NPL was 4.29 (P ¼ 0.00001) and the LOD score 4.16 (dominant model). We also detected suggestive evidence for linkage at chromosome 10q24 under the broad diagnostic category (NPL 3.24, P ¼ 0.0008; heterogeneity LOD score, dominant model 2.65, a ¼ 0.82). Additionally, NPL scores 42.0 were observed at chromosome 2q37, 4p15-16, 7p22, 9q21-22 and 14q11.1-11.2. The linkage we detected at chromosome 6q23 fulfills the criteria for genome-wide significance and is located approximately midway between loci suggested by a previous significant report at chromosome 6q25 and findings located more centromerically at 6q21-22.
Introduction
It is well established that genetic factors play a significant role in the transmission of schizophrenia (MIM 181500, http://www. ncbi.nlm.nih.gov/OMIM/ schizophrenia), a serious neuropsychiatric disorder that has a worldwide prevalence of B1% and is the leading cause of chronic psychiatric hospitalization. Although the precise mode of inheritance is not known, the general assumption is that schizophrenia is a complex genetic disorder in which several susceptibility loci are likely to be involved together with a significant contribution of the environment. 1, 2 The search for these loci, by linkage analysis of family samples and by association studies, has been difficult if not frustrating. Recently, several developments have raised the level of optimism in the field. The first is that linkage to certain chromosomal regions has begun to emerge more consistently. A recent metaanalysis of published genome-wide scans found significant, replicated evidence for linkage on chromosomes 8p21-22, 13q14-32 and 22q11-13. 3 Loci on chromosomes 1q, 2q, 6q and 15q met the significance criterion of the meta-analysis but not the criterion for replication. A second significant development is that three candidate genes located in regions previously identified by linkage analysis have recently been reported to be associated with schizophrenia, although the findings have still to be replicatedFDTNBP1, the human ortholog of the mouse dysbindin gene on chromosome 6p22.3, 4 neuregulin 1 on chromosome 8p 5 and G72, a new gene potentially controlling NMDA function on chromosome 13q34. 6 The Arab Israeli population is a potentially informative focus for linkage studies of schizophrenia. It is an ethnically homogeneous group that has a high birthrate, an unusually high level of consanguinity and a low rate of intermarriage with other population groups in Israel. 7, 8 The public healthcare system in Israel provides centralized mental health care via a network of regional mental health centers. We recruited a sample of Arab Israeli families for linkage analysis of schizophrenia from the catchment area of such a center and performed a genome scan in this sample. Using multipoint, nonparametric and parametric linkage analysis we identified a major susceptibility locus for schizophrenia at chromosome 6q23 as well as obtaining suggestive evidence for linkage at chromosome 10q24.
Materials and methods

Family ascertainment
The Taibe Regional Mental Health Center serves a population of B66 000 living in adjacent Arab Israeli towns and villages in the central region of Israel. Patient files were screened in order to identify probands diagnosed with schizophrenia living in three towns served by the Center, who had at least one first-degree relative with a diagnosis of schizophrenia or schizoaffective disorder. The project was approved by the Helsinki Committee (Internal Review Board) of the HadassahFHebrew University Medical Center and written informed consent was obtained from all subjects. With the permission of the probands, their families were contacted in order to obtain further details of family structure, availability and willingness to participate in the study, and preliminary information on psychiatric illness of first-degree relatives. Concurrently, the files of the Center were searched for additional members of the family who might have been treated there. Nuclear families with at least two individuals apparently affected with schizophrenia or schizoaffective disorder (proband plus sibling or proband plus parent) and at least two other family members, affected or unaffected, available and willing to participate in the study, were selected for further evaluation. The evaluation was conducted in person by two members of the Hadassah research team (KK, OK or NT) and a member of the Center staff fluent in Arabic (MK). Information was obtained on the structure of the extended family and its relationship to other families in the town via the hamulla (clan) to which they belonged. Detailed pedigrees were drawn up and these were updated as the project progressed. For clinical evaluation and DNA sampling, priority was given to families with a higher density of psychiatric illness in the nuclear and extended families. Families with evidence of bilineality were excluded from the study unless there was clear evidence for a first-cousin marriage in the preceding generation.
Diagnostic assessment
Subjects were interviewed with the Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L) 9 and were questioned about psychiatric symptoms in the family according to the Family History Research Diagnostic Criteria (FH-RDC). 10 Medical records of hospitalizations and clinic care were obtained for affected individuals. The completed SADS-L interview form, FH-RDC information and medical records were reviewed by two experienced members of the research team and, in cases where consensus was not achieved, by the principal investigator (BL). Lifetime diagnoses were established according to the Research Diagnostic Criteria (RDC) 11 and the Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV) 12 using a best estimate consensus procedure. 13 All diagnostic evaluations were completed without knowledge of the genotyping data.
The three diagnostic categories that we established were as follows (number of subjects with DNA available under each category and included in the analysis given in parentheses): (i) schizophrenia (n ¼ 52) and schizoaffective disorder, depressed (n ¼ 7) according to RDC (Narrow); (ii) narrow diagnoses plus schizoaffective disorder, manic (n ¼ 3) or depressed and manic (RDC) (n ¼ 4) and unspecified functional psychosis (RDC) (n ¼ 2) (Core); (iii) core diagnoses plus nonaffective psychotic diagnoses that did not clearly fulfill RDC for one of the core diagnoses, that is, brief psychotic episode according to DSM-IV (n ¼ 1), schizophrenia missing one criterion according to RDC (probable schizophrenia) (n ¼ 1) and psychotic disorder not otherwise specified according to DSM-IV (n ¼ 1), schizotypal features according to RDC (n ¼ 2) and also affective psychotic diagnoses according to RDC (ie bipolar disorder, n ¼ 1, and major depression with psychotic features, n ¼ 1) (Broad).
Pedigree sample
Altogether, 51 families have been recruited for the project since its inception. These include 14 extended families in which the illness is segregating in more than one sibship, 17 nuclear families in which there is one sibship with two or more affected members and 20 'trio' families made up of an affected proband plus parents. This gives a total of 321 individuals with DNA of whom 141 are affected. We report here a genome scan of 21 of these families; 12 were nuclear, having one sibship with two or more affected members; nine were extended families with two or more sibships containing affected members ( Table 1 ). The total sample for the analysis consisted of 155 individuals with DNA. The average number of individuals with DNA per family was 7.4; the average number of affected subjects was 2.8 per family for the narrow diagnostic category, 3.2 for the core category and 3.6 for the broad category. Table 1 also provides a breakdown within families of the diagnoses of the schizophrenia susceptibility gene at 6q23 B Lerer et al subjects included in the analysis, under each of the three diagnostic categories.
Genotyping
Blood samples were available from 155 subjects for DNA extraction and in the majority of cases for establishment of immortalized cell lines (at the Herzog Hospital Laboratory). Genotyping was performed at the Center for Genomic Technologies of the Hebrew University of Jerusalem, Israel using 350 microsatellite markers, chosen from the MDC-Genethon microsatellite maps (http://www.genlink.wustl.edu/genethon_frame/). Three of these markers were dropped because of inconsistent results across the sample. For the remaining markers, the average intermarker distance was 10.3 cM. The most intensively covered chromosome was 19 (average intermarker distance 8.90 cM); the least intensively covered was chromosome 14 (12.88 cM). Individual markers (fluorescence-labeled primers from GENSET (France) and Applied Biosystems, (Foster City, CA, USA) were amplified in a PTC 225 DNA Engine (MJ) using 25 ng of DNA, 7 pmol (0.5 mM), of each primer, 1.5 mM MgCl 2 , 0.15 mM dNTPs, 1 Â PCR Gold buffer (15 mM Tris-HCl, pH 8.0, 50 mM KCl) and 0.5 U of AmpliTaq Gold DNA polymerase (both from AB) in a total volume of 14 ml with initial 4 min denaturation at 941C, nine cycles of 20 s at 941C, 20 s at 65-561C (À11C in each cycle) and 20 s at 721C, 22 cycles of 20 s at 941C, 20 s at 551C and 20 s at 721C, 10 min at 721C and hold at 101C. After amplification, labeled PCR products were pooled, up to 10 markers together, and 1-2 ml were sampled into 9 ml of loading buffer (formamide with GENESCAN 400HD [ROX] size standard (Applied Biosystems). PCR product electrophoresis and detection were performed using a 3700 Automated DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Sizing and genotyping were performed using GENESCAN and GENOTYPER software (Applied Biosystems).
We checked for possible genotyping errors and for deviation from Mendelian expectations for all the microsatellites using the program PedManager (made available by Mark Daly, Massachusetts Institute of Technology). Most of the inconsistencies found were resolved by retyping the marker(s) for the specific subject(s). For the few cases where retyping did not solve the inconsistency, we did not consider the given genotype at the particular locus for these subjects. Overall, the laboratory error rate was very low, 14 being B1.2%, when considering the unsolvable errors only and B3% when including resolvable inconsistencies.
Linkage analysis
Relative map positions of the markers were determined according to the distances reported in the Marshfield genetic maps (http://research.marshfieldclinic.org/genetics/Map_Markers/mapmaker/MapForm Frames.html). We analyzed the data with the program Allegro, 15 using the S pairs option and applying an affecteds-only method, where all individuals that are unaffected are treated as phenotype unknown. We estimated the allelic frequencies for the microsatellites from a panel of unrelated, unaffected subjects randomly chosen from the same population as the pedigrees (n ¼ 26) and also from the married-in, unaffected subjects of our families; the frequencies did not differ from each other. The Allegro program calculates both parametric (LOD) and nonparametric (NPL)Fbased on IBD allele sharingFLOD scores, with multipoint calculations, and also allows estimation of a heterogeneity measure of the LOD score (HLOD). 15, 16 Analyzing a complex trait like schizophrenia under a 'simplified' strategy such as a single major locus hypothesis is an oversimplification of the unknown true model of transmission of the disorder; while we can parameterize the analysis to partially compensate for this complexity, the expectations are that in any case not all the families will show linkage to a given locus, because of possible locus heterogeneity. Hence, there is a need to properly evaluate the proportion of families (a) that are linked to the given locus, ultimately aiming at detecting more genetically homogeneous subgroups of the disorder, with an appropriate measure. As such an index, the HLOD has been criticized by some authors 17 but it still represents a valid strategy to detect the contribution Given the wide spacing of the markers and the relatively low number of families analyzed, we also calculated the exponential allele-sharing model (Zlr) originally proposed by Kong and Cox 19 and implemented in the current version of Allegro. This maximum likelihood method compensates for the excessive conservativeness of the traditional NPL.
In order to reduce the number of statistical tests, we employed two models for the parametric analysis, dominant and recessive, even though the special nature of our sample could have warranted inclusion of more complex intermediate models as well. Taking into account the three diagnostic categories there were three models for the nonparametric linkage analysis and with the two genetic models, there were a total of six models for the parametric linkage analysis. The parameters for the dominant model were: q (frequency of the affected allele) ¼ 1%, penetrance for fAa ¼ faa ¼ 90% and phenocopy rate ¼ 0.01% (fAA). The parameters for the recessive model were q ¼ 10%, penetrance faa ¼ 90% and phenocopy rate ¼ 0.01% (fAA ¼ fAa). We chose these parameters to allow for a population prevalence of schizophrenia slightly less than 1%, at the same time avoiding excessive speculation about the hypothetical 'true' parameters that can best describe a single major locus (SML) transmission of the disorder. An error in the 'exact' allelic frequency or in the penetrance parameters can affect the precise estimate of the recombination frequency, hence the precise location of the susceptibility locus, but does not invalidate the model per se.
Calculation of genome-wide significance levels P-values are calculated under the large-sample theory and the criteria to define a linkage as suggestive or definitive are based on Lander and Kruglyak. 20 Lander and Krugkyak 20 originally developed these criteria to compensate for the risk of false-positive findings (type I error) in a genome-wide linkage approach, by correcting the level of nominal significance of the LOD score because of the high number of loci tested. However, this procedure does not consider with equal importance the possibility of type II error, that is the risk of false-negative findings under the same scenario and many researchers consider their approach excessively conservative. 19 Furthermore, the analysis could easily become more complicated, when, as in schizophrenia susceptibility gene at 6q23 B Lerer et al our case, different levels of phenotype definition are required to explore the data in an accurate manner, thus increasing the number of tests not only by the number of loci tested, but also by the levels of phenotype definitions. The debate as to how to correct for all these potential sources of bias (and mostly, 'if' there is the need to correct) is still unresolved and there are no definitive conclusions about the best procedure to follow. We decided to use the Lander and Kruglyak 20 criteria as guidelines to interpret our findings, but we also performed a simulation analysis of our sample to have clearer Simulation analyses performed on our sample, based on 10 000 replicates, to detect the empirical likelihood of falsely detecting linkage, showed that we have a 5% probability to reach an NPL ¼ 3 and 0% probability of reaching NPL ¼ 4 if linkage is not present, thus representing a very low risk of type I error (false-positive findings) If, in addition to considering the number of loci as sources of multiple testing, we also take into account the different levels of phenotype definition, the correction for multiple testing becomes more cumbersome. Correcting a priori for multiple testing implies that all the tests are potentially positive, but this assumption is unrealistic 21 since any Bonferroni-like correction that assumes independent markers and independent level of phenotypes, would markedly overcorrect for the inflated false-positive rate. Thus, a more realistic approach would be either to correct for testing of multiple markers or for the multiple levels of phenotype. If we correct for phenotype levels, our risk of false-positive findings is even lower than if we consider the case of multiple markers. Finally, with a pragmatic approach suggested by Cardon and Bell 21 we can calculate the actual rate of potential false positive findings in our sample by inspecting the outcome of our analyses and correct accordingly. Since our observed number of positive findings is less than 20, any correction would not substantially affect the estimated LOD-score value needed to detect a significant linkage and we assume that the criteria of Lander and Kruglyak 20 can be confidently applied to our study.
Results
Multipoint nonparametric and parametric linkage analyses were performed on the genotypes of 155 individuals at 347 markers distributed over the 22 autosomes, using the Allegro program. Figure 1 shows the NPL tracings for chromosomes 1-22 under the broad diagnostic category and Table 2 gives further details for those loci that showed an NPL 42.0.
The strongest linkage observed was at chromosome 6q23 under the broad diagnostic category. The NPL at marker D6S292 (located 136.97 cM from the pter) was 4.60 (P ¼ 0.000004). The less conservative Zlr was 4.71. The parametric LOD score under a dominant model was 3.33. Under the core diagnostic category, the parametric LOD score was 4.16 ( Table 2 ). The region defined by a decrease of B1.0 in the NPL extended over B12 cM from 131.07 cM (between D6S1715 and D6S292) to 143.69 cM, adjacent to D6S311 (Figure 2 ). The linkage observed in the 6q23 region fulfills the criteria of Lander and Kruglyak 20 for genome-wide significance.
A second locus with evidence for linkage to schizophrenia in this sample was observed at chromosome 10q24. The strongest finding was also under the broad diagnostic category. An NPL of 3.24 (P ¼ 0.0008) centered on D10S187 (135.24 cM). The parametric LOD score was 2.29 with evidence for heterogeneity (HLOD 2.65, a ¼ 0.82). The region of B1.0 cM decrease in NPL was B14 cM extending from D10S543 (128.74 cM from pter) to 140.51 cM, midway between D10S187 and D10S587 (147.57 cM) (Figure 3 ). This finding fulfils the criteria of Lander and Kruglyak 20 for suggestive linkage. Additional loci with NPL scores 42.0 are shown in Table 2 . The highest scores were on chromosomes 7p and 2q. The 7p22 locus (NPL ¼ 2.53, P ¼ 0.006, under the broad diagnostic category), centered on the first marker on chromosome 7, D7S531 (located 5.28 cM from the pter). The LOD score under a dominant model and homogeneity was 2.21. On chromosome 2q37 the NPL at marker D2S345 was 2.42 (P ¼ 0.009) for the core diagnostic category with an HLOD of 2.68 (a ¼ 0.51) under a recessive model. The additional loci with NPL42.0 were at 4p15-16, 9q21-22 and 14q11.1-11.2 (details in Table 2 ). There were Table 3 provides a breakdown under all the diagnostic categories of the NPL scores that exceeded two under at least one diagnostic category. The significant 6q23 locus was strongest under the broad category as was the suggestive locus at 10q 24. However, the findings under the core and narrow categories were also strong for both loci. Two loci yielded their strongest findings under the narrow category and dropped off with extension of the phenotype (4p15-16 and 14q11.1-11.2) while the findings for 2q37 were of similar magnitude under all the diagnostic categories.
Discussion
This genome scan of Arab Israeli families has yielded significant evidence for a schizophrenia susceptibility locus at chromosome 6q23 and suggestive evidence for a locus at chromosome 10q24. There have been several reports of linkage to schizophrenia on chromosome 6q (Table 4 ). The original report of a possible locus in this region came from Cao et al, 22 who studied affected sibling pairs in 53 nuclear families. They found excess allele sharing for markers in the 6q13-26 region, which peaked close to marker D6S416 (P ¼ 0.00024). Multipoint analysis revealed a maximum likelihood score (MLS) of 3.06 close to D6S278 and 3.05 at D6S454/D6S423 with MLS values exceeding 2.4 in the 11.4 cM region between D6S301 and D6S303. The authors analyzed a second dataset made up of 69 families from the NIMH Schizophrenia Genetics Initiative (SGI). The highest allele sharing was at D6S424 (P ¼ 0.0004), D6S283 (P ¼ 0.0009) and B10 cM telomeric to D6S423 (P ¼ 0.0009). The highest multipoint MLS in this second sample was 2.05 at D6S454/D6S423. In a follow-up study by the same group, Martinez et al 23 typed 12 additional markers in the 6q13-23 region and added a second replication sample. This consisted of 43 pedigrees from the US and Australia including 54 independent sib-pairs. Pairwise analysis revealed excess allele sharing that was maximal at D6S424 (P ¼ 0.022). On multipoint analysis with ASPEX, the MLS was 1.07 (P ¼ 0.013). Combining this data set with the NIMH SGI data set, resulted in stronger LOD scores than in the two 24 reported a multicenter, collaborative study encompassing eight samples (including those noted above); 734 pedigrees were included with 824 independent affected sibpairs. Eight markers were typed on chromosome 6q. Multipoint ASP analysis revealed an MLS of 3.10 (P ¼ 0.0036) at 106.9 cM in the combined sample and 2.47 (P ¼ 0.01) when the sample originally reporting linkage in this region was omitted. The NPL was 2.51 (P ¼ 0.0047) at 104.1 cM.
Strong evidence for linkage to schizophrenia was observed more telomerically at 6q25 by Lindholm et al 25 in a very large Swedish pedigree from which 210 individuals (43 affected) were included in a genome scan. They performed parametric linkage analysis. The strongest two-point LOD score (dominant model, affecteds only) was 3.45 at 0 recombination for the marker D6S264 using control allele frequencies (2.59, at 0 recombination, using allele frequencies from the pedigree). With the analysis of additional markers in the region, a LOD score of 6.6 was obtained for D6S253 (173.2 cM) (0.05 recombination). Three-point analyses of markers in the 6q25 region revealed a maximum LOD score of 7.7 between markers D6S253 and D6S297.
Nominal support for linkage of schizophrenia on chromosome 6q was provided by two other reports. In a genome scan of five Austrian families, Bailer et al Taken together with our results, these findings appear to implicate a relatively wide region on chromosome 6q as harboring one or possibly two susceptibility loci for schizophrenia. In this context, the observation of Roberts et al, 28 based on simulation analyses, that even with samples of multiplex families considerably larger than ours there may be substantial chance variation in the location of positive LOD scores for complex disorders, is particularly relevant. The region in which positive findings were reported by Cao et al, 22 Martinez et al 23 At this stage of the investigation, it is hard to predict which genes in the 6q23 area can be potential candidates since the area of our positive finding extends over a rather large chromosomal region, but also because of the uncertainties of the yet uncompleted annotation of the human genome. Refined mapping of our finding will help to better determine the boundaries of the area and shed light on the possible candidate genes.
The suggestive linkage that we observed on chromosome 10q24 is close to the region implicated by Levinson 33 observed a maximum two-point LOD score of 2.27 with D10S1223 under a dominant inheritance model. These findings suggest that there may be two loci for major psychiatric illness on chromosome 10q, a more proximal schizophrenia locus at 10q23-24 and a more distal locus for bipolar disorder at 10q25-26. Alternatively, the various studies may be identifying but imprecisely locating a single locus on chromosome 10q that is implicated in both disorders.
Our finding on chromosome 2q is of interest in the light of a recent report by Paunio et al, 34 who observed a two-point parametric LOD score of 4.43 with the marker D2S427, under a recessive model, in nuclear families affected with schizophrenia from a Finnish genetic isolate. This marker is located at 236.70 cM, proximal to the peak observed in our genome scan, which was at D2S345 (251.25 cM). It is of interest that in our parametric multipoint analysis of this region, the model yielding the highest HLOD was also recessive. Other studies of schizophrenia have reported positive signals in the 2q region (35, 29, 36) but these were at least 100 cM more centromeric in their location.
The sample that we have studied is unique in several respects. It is ethnically homogeneous being entirely recruited from the Arab Israeli population and is centered on three towns in the catchment area of a Regional Mental Health Center serving several adjacent Arab Israeli communities. The three towns were founded approximately 200-250 years ago by a limited number of families. 37 In subsequent years, there was immigration into the towns from the region that constitutes present day Israel and the Palestinian Authority and from the surrounding Arab countries. However, the major population increase has been in the past 75 years, because of a high birthrate and reduced infant mortality. According to the Census conducted by the British Mandatory authorities in 1931, the total population of the three towns at that time was less than 5000 (Palestine Census of Population, November 1931; document held at Israel State Archives, Jerusalem). In 1951, the total population was 11 170; by 1972, it had increased to 25 584 and by 1995 to 51 304. [38] [39] [40] Traditionally, marriages are within the community, often within the same hamulla or extended patrilineal clan and marriages between towns and villages are infrequent. 41 Although there was a steady decline from the 1961-1970 period to the 1991-1998 period (52.9% to 32.8%), the overall frequency of consanguineous marriages in the Arab Israeli Community is high compared to the Jewish population of the country. 7, 8 Compared to the decline in the overall rate of consanguinity, the rate of first cousin marriages has not declined. In the towns from which patients were recruited for this study the frequency of first cousin marriages during the period relevant to our project was as follows: 1961-1965, 23.5%; 1966-1970, 26.8%; 1971-1975, 28 .9%. 8 In the sample included in our genome scan, out of a total of 88 marriages, 26 (29.5%) were between first cousins and in one case one of the partners was also the offspring of a marriage between first cousins. This level of consanguinity would suggest an increased liability to recessive traits; a striking increase in congenital malformations has indeed been reported in these towns. 41 However, the significant linkage to schizophrenia that we observed on chromosome 6q and the suggestive linkage that we observed on chromosome 10q were both strongest under a dominant model of inheritance when analyzed parametrically. This result could represent the existence of a 'true' dominant susceptibility gene or it may be the expression of a pseudodominant transmission rather than a 'true' recessive effect of a susceptibility gene. This effect can be attributed to high consanguinity because of first-cousin (and more distantly related) marriages. Whatever the case, the uniqueness of our population does not reside only in the high level of consanguinityFthat facilitated the detection of a genetic component of the susceptibility to schizophreniaFbut in its striking homogeneity in terms of origin. Since the population originated less than 30 generations ago with a limited number of founders, the degree of linkage disequilibrium (LD) is still quite high across large stretches of DNA, allowing the genes involved in a complex trait like schizophrenia to be mapped in a very efficient way. In this case, for example, the high information content of a microsatellite markerFor better still of a pair of microsatellites in LDFcan identify a susceptibility locus even when the relevant susceptibility allele has a low frequency. 42 The large extent of the LD can also help to identify 'complex' alleles, where more than a single polymorphism plays a functional role in enhancing the risk to develop the disorder. 6 In linkage studies of complex disorders, definition of the phenotype is a potential weakness, from which our study is not immune. We employed three nested diagnostic levels. Our decision to include schizoaffective depressed (RDC) in the narrow category together with schizophrenia parallels that of the NIMH Schizophrenia Genetics Initiative. 27, 35 It was motivated by previous reports suggesting that schizoaffective disorder may be genetically heterogeneous with subtypes that are variants of schizophrenia and affective disorder respectively. 43, 44 We included unspecified functional psychosis (RDC) in the core category because in our experience absence of key information that is sometimes difficult to elicit can result in patients receiving this diagnosis rather than schizophrenia. In view of an increasing number of reports implicating the same loci in schizophrenia and bipolar disorder 45, 3 our broad diagnostic category was defined so as to include both affective and nonaffective psychotic diagnoses as well as nonaffective psychoses at the probable level. In effect, however, there were only two subjects with nonaffecschizophrenia susceptibility gene at 6q23 B Lerer et al tive psychotic diagnoses. In the absence of a consensus regarding the phenotypic boundaries of schizophrenia, it is impossible to categorically establish whether the phenotypic categories we applied are correct or not. Certainly, variation of the phenotype can have substantial influence on LOD scores. 46 In our study, the highest nonparametric LOD scores were obtained with the broad phenotype compared to the core and narrow categories. However, results under the core category were also strong for both the 6q23 and 10q24 loci. For two loci with NPL scores 42.0 (4p15-16 and 14q11.1-11.2) the direction was opposite, with highest NPL scores being under the narrow diagnostic category. Overall, the precise schizophrenia phenotype to which the significant, suggestive and putative loci that we identified are related, cannot be established at this stage.
In conclusion, applying multipoint model-free and parametric linkage analysis to an ethnically homogeneous, inbred sample of Arab Israeli families, we have observed significant evidence for a schizophrenia susceptibility locus at chromosome 6q23 and suggestive evidence for a locus at chromosome 10q24. Both loci are in regions previously implicated in genome scans of schizophrenia in other populations although results for these regions have been negative in several other large studies. The family cohort that we analyzed is part of a larger sample of families recruited from the Arab Israeli population in the same region of the country. To the extent that locus heterogeneity is a tenable hypothesis in relation to complex disorders in general and schizophrenia in particular, this extended sample is available to us for further studies aimed at narrowing down the linked regions by fine mapping and identifying susceptibility genes for schizophrenia by linkage disequilibrium and association methods.
